Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 182 publications
Situational Prevention of Migraine Attacks: Can Early Treatment Change the Conversation?
Journal: Drugs
Published: July 22, 2025
Computational chemistry-based structure-guiding engineering of ω-transaminases to enhance catalytic activity and enantioselectivity toward bulky ketones.
Journal: International journal of biological macromolecules
Published: July 07, 2025
Pharmacological characterization of ubrogepant and atogepant in cAMP assays at human, rat, and mouse calcitonin family receptors in transfected cells.
Journal: Biochemical pharmacology
Published: June 13, 2025
Ubrogepant alleviates migraine premonitory symptoms.
Journal: Nature reviews. Neurology
Published: June 09, 2025
Adverse events associated with gepants: a pharmacovigilance analysis based on the FDA adverse event reporting system.
Journal: The journal of headache and pain
Published: May 23, 2025
Expert consensus on gepants for acute and preventive treatment of migraine in Thailand.
Journal: The journal of headache and pain
Published: April 23, 2025
A fixed-dose combination of meloxicam and rizatriptan (Symbravo) for migraine.
Journal: The Medical letter on drugs and therapeutics
Published: April 22, 2025
Head-to-head relief: ubrogepant, rimegepant, and zavegepant in migraine treatment.
Journal: Pain management
Published: April 16, 2025
Efficacy of ubrogepant and atogepant in males and females with migraine: A secondary analysis of randomized clinical trials.
Journal: Cephalalgia : an international journal of headache
Published: February 21, 2025
Ubrogepant, erenumab, and eptinezumab antagonize positive inotropic effects of the calcitonin gene-related peptide in the isolated human atrium.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: February 19, 2025
Last Updated: 10/31/2025